New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…
June 21, 2025 18:00 ET | Source: BioAge Labs, Inc. Treatment with apelin receptor agonist enhanced glycemic control and demonstrated…
CHICAGO, June 21, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to…
Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic pancreatic cancer (mPDAC) treated with elraglusib June 20,…
This award recognizes Oper8 Global Group's innovation in edge data center for artificial intelligence and high-performance computing, and its commitment…
BOSTON, June 18, 2025 /PRNewswire/ -- Starburst, the data platform for apps and AI, today announced it has been recognized…
The recognition showcases Airsys's groundbreaking advancements in energy-efficient cooling, thermal innovation, and sustainability for high-density data centers SAN ANTONIO, June…
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused…
NEW YORK and PUNE, India, June 18, 2025 /PRNewswire/ -- Straive, a global leader in Data, Analytics, and AI Operationalization,…
NEW YORK, June 16, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
